Results 1 to 10 of about 80,729 (260)

Composite follicular lymphoma and classic Hodgkin lymphoma [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2022
Composite lymphoma is very rare and a combination of Hodgkin lymphoma and non-Hodgkin lymphoma and even histiocytic tumors can occur. Because of the unfamiliarity, not only can this cause diagnostic problems, but can also affect treatment plan. We report
Han-Na Kim   +5 more
doaj   +1 more source

Hodgkin lymphoma [PDF]

open access: yesNature Reviews Disease Primers, 2020
Hodgkin lymphoma (HL) is a B cell lymphoma characterized by few malignant cells and numerous immune effector cells in the tumour microenvironment. The incidence of HL is highest in adolescents and young adults, although HL can affect elderly individuals.
Joseph M, Connors   +6 more
openaire   +4 more sources

EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: Epstein Barr Virus - positive Hodgkin lymphoma is defined by the presence of Epstein-Barr virus (EBV) in tumor cells. EBV plays an important role in the development and prognosis of Hodgkin's lymphoma.
Rana Habeeb   +2 more
doaj   +1 more source

Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease

open access: yesCells, 2023
Ophelia syndrome is characterized by the coincidence of severe neuropsychiatric symptoms, classical Hodgkin lymphoma, and the presence of antibodies to the metabotropic glutamate 5 receptor (mGluR5).
Sofia Schnell   +8 more
doaj   +1 more source

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma

open access: yesPathology and Oncology Research, 2023
Composite mantle cell lymphoma and classical Hodgkin lymphoma is very rare and the actual origin of it is still unclear. Here we reported a new case of composite mantle cell lymphoma and classical Hodgkin lymphoma and analyzed its molecular changes ...
Hongyu Wang   +4 more
doaj   +1 more source

Head and Neck Lymphoma in an Iranian Population [PDF]

open access: yesIranian Journal of Otorhinolaryngology, 2017
Introduction: This study is aimed to assess the prevalence and characteristics of head and neck lymphoma in a defined group of an Iranian population.   Materials and Methods: In this retrospective study, 126,450 biopsy reports from two referral Pathology
Nafiseh Shamloo   +5 more
doaj   +1 more source

Hodgkin lymphoma [PDF]

open access: yesJournal of Clinical Investigation, 2012
Hodgkin lymphoma (HL), a B cell-derived cancer, is one of the most common lymphomas. In HL, the tumor cells--Hodgkin and Reed-Sternberg (HRS) cells--are usually very rare in the tissue. Although HRS cells are derived from mature B cells, they have largely lost their B cell phenotype and show a very unusual co-expression of markers of various ...
Ralf, Küppers   +2 more
openaire   +2 more sources

A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report

open access: yesSAGE Open Medical Case Reports, 2023
In this report, we present the case of vanishing bile duct syndrome in the setting of classical Hodgkin lymphoma. Vanishing bile duct syndrome was diagnosed retrospectively in this patient with Hodgkin lymphoma, who initially presented with a hepatic ...
Bharat Patodiya   +5 more
doaj   +1 more source

Immunohistochemical Expression of B Cell Transcription Factors in Hodgkin’s Lymphoma and Their Use in Differential Diagnosis

open access: yesJournal of Contemporary Medicine, 2023
Aim: Classical Hodgkin lymphoma is common, it is one of the lymphomas whose differential diagnosis can be difficult. It is thought that Hodgkin cell may originate from the germinal center.
Yiğit Şenol   +2 more
doaj   +1 more source

CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma

open access: yesHaematologica, 2018
Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better tumor-specific target therapy in Hodgkin lymphoma patients with refractory or relapsed disease ...
Ziduo Li   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy